Bio-Gene Technology Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.811x

Bio-Gene Technology Ltd cash flow conversion efficiency. Based on the latest financial reports, Bio-Gene Technology Ltd (BGT) has a cash flow conversion efficiency ratio of -0.811x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-946.61K ≈ $-669.78K USD) by net assets (AU$1.17 Million ≈ $825.57K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bio-Gene Technology Ltd (2014–2025)

Cash flow conversion efficiency of Bio-Gene Technology Ltd from 2014 to 2025. This chart illustrates how Bio-Gene Technology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bio-Gene Technology Ltd (BGT) stock price for real-time trading data and today's change.

Bio-Gene Technology Ltd Cash Flow Conversion Ratio Explained

Bio-Gene Technology Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bio-Gene Technology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Gene Technology Ltd ranked by their cash flow conversion efficiency. Also see Bio-Gene Technology Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
M3 Mining Ltd AU:M3M	-0.538x
Focus Universal Inc NASDAQ:FCUV	-6.068x
GSS Infotech Limited NSE:GSS	-0.041x
Goenka Diamond and Jewels Limited NSE:GOENKA	0.000x
Science Group plc LSE:SAG	0.102x
Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares NASDAQ:AZI	-0.029x
hGears AG XETRA:HGEA	-0.050x
MODERN LAND (CHINA) DL-01 F:7PJ	N/A

Annual Cash Flow Conversion Efficiency for Bio-Gene Technology Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Gene Technology Ltd from 2014 to 2025. Review Bio-Gene Technology Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.63 Million ≈ $1.15 Million	AU$-2.54 Million ≈ $-1.80 Million	-1.563x	-58.38%
2024-06-30	AU$2.79 Million ≈ $1.97 Million	AU$-2.75 Million ≈ $-1.95 Million	-0.987x	+2.98%
2023-06-30	AU$3.22 Million ≈ $2.28 Million	AU$-3.28 Million ≈ $-2.32 Million	-1.017x	-14751.29%
2022-06-30	AU$6.27 Million ≈ $4.44 Million	AU$43.52K ≈ $30.79K	0.007x	+101.61%
2021-06-30	AU$4.25 Million ≈ $3.00 Million	AU$-1.83 Million ≈ $-1.29 Million	-0.430x	-56.90%
2020-06-30	AU$6.00 Million ≈ $4.25 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.274x	+38.40%
2019-06-30	AU$4.95 Million ≈ $3.50 Million	AU$-2.20 Million ≈ $-1.56 Million	-0.445x	-29.44%
2018-06-30	AU$6.91 Million ≈ $4.89 Million	AU$-2.37 Million ≈ $-1.68 Million	-0.344x	-327.50%
2017-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-729.15K ≈ $-515.92K	-0.080x	+90.93%
2016-06-30	AU$473.35K ≈ $334.92K	AU$-419.35K ≈ $-296.71K	-0.886x	-440.17%
2014-06-30	AU$290.03K ≈ $205.21K	AU$-47.57K ≈ $-33.66K	-0.164x	--

About Bio-Gene Technology Ltd

AU:BGT Australia Biotechnology

Market Cap

$2.81 Million

AU$3.97 Million AUD

Market Cap Rank

#29550 Global

#1659 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.04

All Time High

AU$0.34